Signs – Smoke Master https://smoke.vmondeika.com The ultimate smoking source Tue, 01 Sep 2026 08:32:53 +0000 en-US hourly 1 https://wordpress.org/?v=7.1.1 https://smoke.vmondeika.com/wp-content/uploads/2026/01/cropped-SMG_logo_favicon-32x32.png Signs – Smoke Master https://smoke.vmondeika.com 32 32 California Governor Signs Bill Restricting Marijuana Packaging That’s ‘Attractive To Children’ https://smoke.vmondeika.com/california-governor-signs-bill-restricting-marijuana-packaging-thats-attractive-to-children/ Tue, 01 Sep 2026 08:32:53 +0000 https://smoke.vmondeika.com/california-governor-signs-bill-restricting-marijuana-packaging-thats-attractive-to-children/

California’s governor has signed a bill to more clearly define the types of marijuana packaging and labeling that is prohibited due to appealing to children.

Gov. Gavin Newsom (D) gave final approval to the legislation from Assemblymember Jacqui Irwin (D) on Monday, about two weeks after it passed the Assembly in a vote of 69-1 and cleared the Senate 38-0.

“When voters legalized adult-use cannabis, they also made clear that California must protect children and ensure cannabis products are sold in a tightly regulated marketplace,” the governor said in a press release. “Today we are setting clearer, enforceable standards that protect kids, strengthen accountability, and give responsible businesses the certainty they need to follow the rules.”

As enacted into law, AB 2249 defines “attractive to children” to mean designed or likely to appeal to people under the age of 21.

Indications for that youth appeal include the use of cartoons, depictions of individuals who appear to be under 21, use of mythological creatures like unicorns or dragons or references to celebrities or characters who are primarily associated with children’s entertainment.

It also includes images of consumable goods that are primarily marketed to children—such as candies, cereals, sweets and desserts—as well as the use of lettering styles resembling “overinflated bubbles or balloons” that are typical in products marketed to kids.

“Cannabis and cannabis product packaging and labeling shall not imitate, mimic, or closely resemble the packaging, labeling, trade dress, or overall appearance of a non-cannabis product that is primarily marketed to children,” the legislation says.

While the new law says that “edible cannabis product or vape cartridge labeling shall not include cartoon or overly stylized depictions of fruit,” one provision clarifies that “realistic depictions of fruit used to identify or accurately depict the product ingredients or production region are not prohibited.”

The packaging and labeling restrictions are set to take effect on January 1, 2028 now that the measure has been enacted into law.


Marijuana Moment is tracking hundreds of cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments.


Learn more about our marijuana bill tracker and become a supporter on Patreon to get access.

Under the legislation, the Department of Cannabis Control (DCC) is directed to adopt regulations to “address additional packaging and labeling design elements or product characteristics that pose heightened risk to children.”

DCC will also be required to develop “compliance assessment resources” to help cannabis businesses self-evaluate whether their packaging and labeling at attractive to children.

In June, the department rolled out a new AI tool to help businesses identify marijuana product packaging may appeal to kids in violation of existing state rules, which already ban cartoons on cannabis labels.

Irwin, the bill’s sponsor, previously requested the California State Auditor to conduct an assessment of DCC’s enforcement of existing laws against marketing cannabis products to children.

That audit “confirmed what many have long recognized: California’s cannabis industry continues to package and market products in ways which are overtly attractive to children,” the lawmaker said.

“Since the passage of Proposition 64, child cannabis poisonings have increased dramatically. These exposures are often driven by cannabis product packaging that uses features which are explicitly attractive to children, leading children to consume the products unintentionally,” Irwin said. “Young children who accidentally consumer cannabis require poison control treatment consistently, and in many cases they can also expose their fellow elementary and middle school peers to cannabis.”

The California Cannabis Industry Association (CCIA), for its part, opposed the bill.

“AB 2249 would impose significant costs on the licensed businesses that already keep cannabis away from children, undermine the state’s efforts to bring consumers into the regulated market, and does not address safe at-home storage practices,” the trade association said.

The measure was amended by the Senate after initially clearing the Assembly, including by delaying its effective date, narrowing the definition of “attractive to children” and removing some requirements for regulators.

Meanwhile, lawmakers this session have also advanced legislation to allow marijuana retailers to offer drive-thru windows to serve customers.

California’s treasurer recently said the marijuana legalization law that voters approved a decade ago has been a “complete failure” and should be replaced with a new ballot initiative that prioritizes consumers and small businesses.

The vice chair of the state Senate Budget Committee has floated the idea of putting a new initiative on the state ballot to “reverse” Proposition 64, for example, arguing that voters were misled and voicing concerns about the health impacts of marijuana use.

Republican gubernatorial candidate Steve Hilton, who is endorsed by President Donald Trump, recently told Marijuana Moment that taxes and regulations on cannabis are “too high.”

DCC recently released data showing how 97 percent of state cannabis enforcement actions in unincorporated cities have happened in counties that have locally banned licensed growers from operating.

California regulators also recently adopted emergency rules changes for the state’s marijuana licensing process that are intended to make it easier for businesses to qualify for benefits in line with the Trump administration’s recent move to federally reschedule medical cannabis.

Newsom recently took credit for helping to lead the push for the state to legalize marijuana and discussed his own limited experience with using cannabis.

Last October, however, Newsom vetoed a bill that would have allowed certain marijuana microbusinesses to ship medical cannabis products directly to patients via common carriers like FedEx and UPS, stating that the proposal “would be burdensome and overly complex to administer.”

Newsom did sign a bill earlier that month aimed at streamlining research on marijuana and psychedelics.

Last September, the governor also signed a measure into law to put a pause on a recently enacted tax hike on marijuana products.

Separately, the state attorney general says Indian tribes cannot independently engage in marijuana commerce with licensed cannabis businesses without first obtaining their own commercial license from state officials.

California officials recently awarded nearly $30 million in grants for marijuana-focused academic research projects.

Source link

]]>
Puerto Rico Governor Signs Psychedelics Executive Order https://smoke.vmondeika.com/puerto-rico-governor-signs-psychedelics-executive-order/ Wed, 05 Aug 2026 20:44:13 +0000 https://smoke.vmondeika.com/puerto-rico-governor-signs-psychedelics-executive-order/ “We are moving toward making Puerto Rico a leader in clinical research and opening new opportunities for our patients, researchers, healthcare professionals, and veterans.”

By Jack Gorsline, Psychedelic State(s) of America

In a significant move aimed at overhauling Puerto Rico’s approach to severe mental health and substance use disorders, Gov. Jenniffer González-Colón (R) signed an executive order on Tuesday designed to transform the U.S. territory into a pioneering hub for clinical research into emerging medical therapies, including the investigational use of ibogaine.

Executive Order 2026-037 will create a comprehensive assessment regarding the feasibility and advisability of establishing a “Pilot Clinical Research Program for Emerging Therapies.” The program would lay the crucial groundwork for highly regulated clinical trials involving novel and historically restricted therapeutic compounds, prioritizing scientific rigor and strict adherence to both state and federal regulatory frameworks.

The administration cited the island’s ongoing battle with complex mental health challenges, neurodegenerative diseases and escalating substance use disorders as the primary catalyst for the new public policy.

Recognizing that existing treatments often fall short for vulnerable populations, the government is looking toward novel compounds like ibogaine—a psychoactive alkaloid being studied globally for its potential to interrupt severe opioid and substance-use addictions—as well as other emerging therapeutics, like psilocybin and MDMA.

“Scientific innovation represents an opportunity to transform the future of Puerto Rico’s healthcare system,” González-Colón said during a signing ceremony at La Fortaleza, the governor’s official residence. “Our responsibility is to prepare the island to participate in the research that will define tomorrow’s treatments, always with the highest standards of scientific rigor, ethics and regulatory compliance.”

“Through this Executive Order, we are moving toward making Puerto Rico a leader in clinical research and opening new opportunities for our patients, researchers, healthcare professionals, and veterans,” she added.

Under the new directive, the Puerto Rico Department of Health is tasked with leading a strategic effort to build out the scientific, regulatory and operational infrastructure required to host cutting-edge, multicenter clinical trials. The order highlights that Puerto Rico already possesses a robust foundation to support this endeavor, citing the island’s strong academic, hospital and scientific infrastructure, which includes major universities, established research centers and highly trained medical professionals.

Advocacy organizations across the island, including the Colectivo Psicodélico de Puerto Rico (also known as the Puerto Rico Psychedelic Collective) heralded the executive order as a watershed moment for Puerto Rico’s psychedelic ambitions. 

“As a psychedelic community, we celebrate this executive order as a meaningful signal that Puerto Rico’s government is beginning to take seriously the emerging evidence base around psychedelic therapies: Dr. Juliana Millán Torres, founder of the CPPR, told Psychedelic State(s) of America. 

“The archipelago is catching up to a global movement, and that fills us with hope” Millán Torres added. 

To ensure the program adheres to the highest medical, scientific and ethical standards, the executive order mandates the creation of a specialized Scientific and Regulatory Advisory Committee housed within the Department of Health. The governor will directly appoint the committee’s members, who will be drawn from a diverse pool of government officials and subject matter experts.

The advisory body will feature specialists in clinical research, public health, bioethics, pharmacology, neurology, psychiatry, psychology and regulatory affairs. These advisors will be charged with evaluating current scientific evidence surrounding emerging therapies; assessing the logistical, clinical, ethical, and financial viability of the pilot program; and identifying necessary upgrades to the island’s physical infrastructure and medical workforce training.

Furthermore, the committee will be responsible for drafting a Strategic Agenda to bolster clinical research across Puerto Rico, pinpointing priority areas for scientific inquiry, and fostering collaborative research opportunities with public, private, academic and federal entities.

Underpinning this clinical research initiative is Puerto Rico’s formidable $50 billion pharmaceutical legacy, which has long cemented the island as an indispensable anchor in the broader medical supply chain across the United States and both North and South America. Sustaining tens of thousands of local STEM and manufacturing jobs, the territory’s medical equipment and life sciences export sector is a global powerhouse that currently produces roughly 90 percent of the world’s pacemakers, alongside massive quantities of contact lenses, insulin pumps and glucose monitors. Puerto Rico’s robust, world-class manufacturing infrastructure provides a well-established foundation to support the administration’s ambitious pivot toward cutting-edge clinical trials and emerging therapeutics.

A prominent component of the executive order is its dedicated focus on Puerto Rican military veterans. The Department of Health is explicitly instructed to coordinate with the Office of the Puerto Rico Veterans Advocate to “facilitate educational initiatives and explore potential avenues for veterans to safely participate in the clinical trials.” Any participation would be strictly governed by rigorous eligibility criteria, available scientific evidence, and necessary regulatory authorizations.

The territory’s new public policy also formally references a broader federal directive to align its objectives. The order links Puerto Rico’s efforts with an executive order signed by President Donald Trump back in April, which aims to accelerate the development of innovative medical treatments for serious mental illnesses by fostering cooperation among government agencies, the private sector, and research institutions.

González-Colón’s push for advanced clinical research occurs against a turbulent political backdrop in Puerto Rico following recent revelations that the Department of Justice halted a major election fraud investigation involving her 2024 campaign. According to an investigation by ProPublica, federal narcotics agents had gathered solid evidence that “Los Tiburones,” a notorious Puerto Rican prison gang, allegedly coerced addicted inmates into voting for González-Colón during the gubernatorial primary by offering narcotics in exchange for their support, while simultaneously threatening violence and withholding drugs from those who refused. 

To achieve the ambitious goals outlined in the executive order, the Puerto Rico Department of Health is authorized to coordinate its efforts across a wide array of state and federal bodies. The order encourages direct collaboration with university networks, hospital systems, nonprofit organizations, and crucial federal partners. 

The order also states that the directive does not authorize the widespread or routine clinical use of emerging psychedelic therapies, including ibogaine, psilocybin, MDMA or any other compounds currently under investigational status. Instead, the administration emphasized that the singular purpose of the directive is to fortify the scientific and institutional readiness of Puerto Rico’s healthcare system. 

Looking ahead, the newly established Scientific and Regulatory Advisory Committee will operate on a strict reporting timeline. The panel is required to submit initial progress reports to the Department of Health, culminating in a final report detailing its findings and recommendations. González-Colón will then review the committee’s assessment to determine appropriate administrative actions and subsequent public policy measures required to launch the pilot program.

In any event, advocates on the ground aren’t slowing down anytime soon.

“It’s an exciting time to continue doing the work that needs to be done in service of a shared purpose, work that will hopefully ripple out into every part of our islands.” said Millán Torres.

“The momentum is here to be embraced by the public, healthcare providers, researchers, community members, and everyone contributing in the psychedelic space, as we build this future together.”



Source link

]]>
Virginia Governor Signs Bills To Protect Marijuana Users’ Parental Rights And Allow Medical Use In Hospitals https://smoke.vmondeika.com/virginia-governor-signs-bills-to-protect-marijuana-users-parental-rights-and-allow-medical-use-in-hospitals/ Tue, 14 Apr 2026 03:50:06 +0000 https://smoke.vmondeika.com/virginia-governor-signs-bills-to-protect-marijuana-users-parental-rights-and-allow-medical-use-in-hospitals/

Virginia’s governor has signed bills to allow patients to use medical marijuana in hospitals and protect the parental rights of cannabis consumers.

Gov. Abigail Spanberger (D) on Monday also also recommended that lawmakers adopt amendments to legislation that is aimed at providing resentencing relief to people with prior marijuana convictions.

Meanwhile, advocates are awaiting her action on separate bills to legalize and regulate recreational marijuana sales in the state ahead of a midnight deadline.

Here’s a look at the cannabis legislation that Spanberger has already acted on:

Protect Marijuana Consumers’ Parental Rights

The governor signed a bill to protect the rights of parents who use marijuana in compliance with state law.

HB 942 from De; Nadarius E. Clark (D) states that a “person’s legal possession or consumption of substances…alone shall not serve as a basis to restrict custody or visitation unless other facts establish that such possession or consumption is not in the best interest of the child.”

The new law also specifies that a parent or legal guardian can’t be construed to have failed a drug test over legal substances such as cannabis.

The legislation is consistent with a measure Clark sponsored last session that advanced through the legislature, only to be vetoed by then-Gov. Glenn Youngkin (R).

“This is a significant victory for Virginia parents who consume cannabis responsibly,” JM Pedini, development director for the advocacy group NORML and executive director for Virginia NORML, told Marijuana Moment. “It’s taken seven legislative sessions to secure these most basic protections and prevent courts from needlessly separating children from their families.”

Allow Patients To Use Medical Cannabis In Hospitals

Spanberger additionally signed legislation to let patients use medical marijuana in hospitals.

SB 332 from Sen. Barbara Favola (D) and HB 75 from Del. Karen Keys-Gamarra (D) build upon existing state law protecting health professionals at hospices, nursing homes and assisted living facilities that aid terminally ill patients in utilizing medical cannabis treatment from punishment by adding hospitals to the statute.

The new law also creates a working group under the Department of Health to “discuss the implementation process for providing cannabis products to patients within medical care facilities.”

“The work group shall assess any available federal guidance or proposed regulations on the use of cannabis products or changes to the schedule for cannabis products under the federal Controlled Substances Act (21 U.S.C. § 801 et seq.) as well as interaction with applicable state laws,” the legislation says.

Its members will include representatives of the Virginia Hospital & Health Care Association and the Virginia Health Care Association, as well as health care providers and palliative, hospice, and hospital volunteers familiar with issues associated with providing care to individuals experiencing chronic illness.

The measure directs the working group to submit a report to key legislative committees including “written guidelines for the use of medical cannabis within medical care facilities and the safe operations of medical care facilities” by November 1.

Meanwhile, the governor also proposed that lawmakers amend legislation to provide resentencing relief for prior cannabis convictions:

Provide Resentencing Relief For Prior Cannabis Convictions

Lawmakers sent Spanberger bills to allow people who have certain marijuana convictions on their records to receive resentencing relief, but she wants them to make changes.

As approved by lawmakers, SB 62 from Senate President Pro Tem Louise Lucas (D) and HB 26 from Rozia Henson, Jr. (D) would create a process by which people who are incarcerated or on community supervision for certain felony offenses involving the possession, manufacture, selling or distribution of marijuana could receive an automatic hearing to consider modification of their sentences.

The relief would apply to people whose convictions or adjudications are for conduct that occurred prior to July 1, 2021, when a state law legalizing personal possession and home cultivation of marijuana went into effect.

Under the governor’s proposed amendments, affected persons would have to proactively file petitions to get the relief instead of having the courts proceeding automatically. Spanberger’s suggestion also removes deadlines for court hearings on resentencing relief.

Similar legislation was approved by lawmakers last session but it was vetoed by Youngkin, the former governor.

Lawmakers are set to reconvene to address the governor’s proposals on this and other bills on April 22.

Source link

]]>
Oregon Governor Signs Bill To Allow Medical Marijuana Use In Hospices And Other Health Facilities https://smoke.vmondeika.com/oregon-governor-signs-bill-to-allow-medical-marijuana-use-in-hospices-and-other-health-facilities/ Fri, 10 Apr 2026 14:53:53 +0000 https://smoke.vmondeika.com/oregon-governor-signs-bill-to-allow-medical-marijuana-use-in-hospices-and-other-health-facilities/

Oregon’s governor has signed a bill to allow patients with debilitating medical conditions to access medical marijuana in certain health facilities such as hospices.

Gov. Tina Kotek (D) approved the legislation from Rep. Farrah Chaichi (D) on Tuesday after it cleared the Senate in a 20-8 vote last month and was passed by the House of Representatives in a 39-3 vote in February.

Chaichi said in testimony to the Senate Health Care Committee that the bill is “an important tool to facilitate cannabis use as an alternative or addition to opioid use in end of life care.”

“While sometimes necessary, opiates are often overly sedative, preventing quality family interaction in someone’s final days,” she said. “As someone who lost my mother while she was intubated, I know how meaningful it is for patients to be present and in the moments of their last days and weeks with their loved ones. This is a quality of life and a quality of care issue. The bill’s goal is to ensure patients who desire this important and valid medical treatment have access across the board.”

As enacted, HB 4142 will require hospice, palliative and home care organizations, as well as residential facilities, to develop rules permitting registered patients with debilitating conditions to use medical cannabis.

The reform is similar to—albeit somewhat more limited than—multiple “Ryan’s law” measures that have advanced in state legislatures across the country. Ryan’s law, which is named after a young cannabis patient in California who passed away, generally refers to a policy broadly permitting medical marijuana use in health facilities such as hospitals.

The Oregon bill doesn’t extend to hospitals, but it builds upon the state’s medical cannabis program in a way that advocates say will meaningfully improve quality of life for seriously ill patients.

Under the proposal, the Oregon State Board of Nursing will further be prohibited “from disciplining a nurse who discusses the medical use of marijuana with a patient,” according to a legislative summary. It will additionally make it so eligible health facilities can act as medical marijuana caregivers if authorized by regulators.

The legislation “exempts residential facilities that provide a patient with medical marijuana from criminal laws related to the possession, delivery, or manufacture of marijuana” and “allows a conditionally designated residential facility to develop a written policy and train staff before the operative date,” the summary says.

Now that the governor has signed the measure, it is set to become operative on January 1, 2027.

Source link

]]>